ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 217 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $47,000 | -13.0% | 1,148 | +1.2% | 0.01% | -25.0% |
| Q2 2020 | $54,000 | +12.5% | 1,134 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $48,000 | -2.0% | 1,134 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $49,000 | +22.5% | 1,134 | 0.0% | 0.01% | +12.5% |
| Q3 2019 | $40,000 | +33.3% | 1,134 | 0.0% | 0.01% | +33.3% |
| Q2 2019 | $30,000 | -86.2% | 1,134 | -86.1% | 0.01% | -86.7% |
| Q1 2019 | $218,000 | +66.4% | 8,134 | 0.0% | 0.04% | +40.6% |
| Q4 2018 | $131,000 | -43.3% | 8,134 | -26.9% | 0.03% | -25.6% |
| Q3 2018 | $231,000 | +29.1% | 11,134 | -5.5% | 0.04% | +19.4% |
| Q2 2018 | $179,000 | -31.2% | 11,784 | +71.2% | 0.04% | -57.1% |
| Q3 2017 | $260,000 | +28.7% | 6,884 | +10.4% | 0.08% | +9.1% |
| Q1 2017 | $202,000 | – | 6,234 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |